Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy

Outlet: The Hindu · Published 21/10/2026 09:50 UTC

Only The Hindu reports this: no contrast yet

None of the other outlets we follow has reported this story, so there are no versions to compare. If others publish it or data appear that test it, it will move to the comparison.

Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma

Read on the original outlet ↗

Capture record

Source: https://www.thehindu.com/news/cities/Hyderabad/bharat-biotech-arm-nucelion-vegen-bio-to-partner-for-car-t-therapy/article71606870.ece
Published: 21/10/2026 09:50 UTC
Captured: 21/10/2026 10:08 UTC
Text fingerprint: 76c7673aa6f66baf · 414 words
Changes detected: 0
Archived copy: Wayback Machine ↗

The fingerprint (sha256) and the capture date prove what the story said when we analysed it, even if it changes later.